phlorhizin has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, RF; Coombs, MRP; Fernando, W; Hoskin, DW; Rupasinghe, HPV | 1 |
| Coyle, K; Fernando, W; Hoskin, DW; Marcato, P; Vasantha Rupasinghe, HP | 1 |
2 other study(ies) available for phlorhizin and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Phloridzin Docosahexaenoate Inhibits Spheroid Formation by Breast Cancer Stem Cells and Exhibits Cytotoxic Effects against Paclitaxel-Resistant Triple Negative Breast Cancer Cells.
Topics: Antineoplastic Agents; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Docosahexaenoic Acids; Female; Humans; Neoplastic Stem Cells; Paclitaxel; Phlorhizin; Triple Negative Breast Neoplasms | 2023 |
Phloridzin docosahexaenoate, a novel fatty acid ester of a plant polyphenol, inhibits mammary carcinoma cell metastasis.
Topics: Animals; Cell Line, Tumor; Cell Movement; Docosahexaenoic Acids; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Injections, Intraperitoneal; Lung Neoplasms; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Phlorhizin; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2019 |